Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
The Sickle Cell Disease Partnership is a multi-sector collaboration of healthcare stakeholders committed to advancing actionable federal healthcare policies that will improve the lives of patients living with Sickle Cell Disease.
The Partnership’s main objective is to work collaboratively across the Sickle Cell Disease community to translate the recommendations of the National Academies’ foundational report into legislative and administrative actions in Congress and the Executive Branch. Their vision is a day when every individual with Sickle Cell Disease in the United States lives to his or her fullest potential because the individual has timely, sustained access to high-quality, equitable, coordinated care and treatment.
Related Content
- 
                                                                    
                            
                        
                        
                                                    What it’s like to be 17 and living with sickle cell diseaseTre Adegoroye is 17 and was diagnosed wi...
 - 
                                                                    
                            
                        
                        
                                                    Identifying central sensitization in adults with sickle cell disease: Differences in clinical features and psychobeh...Central sensitization (CS) has been iden...
 - 
                                                                    
                            
                        
                        
                                                    Music therapy helps relieve pain in adults with sickle cell disease, pilot trial suggestsMusic therapy can help ease pain in ad...
 - 
                                                                    
                            
                        
                        
                                                    Barbara Speller Brown, DNP, MSNBarbara Speller-Brown, DNP, MSN, PNP-BC,...
 - 
                                                                    
                            
                        
                        
                                                    Sustainability of Hematological and Clinical Benefits to HU Administration in the Prevention of Sickle-Cell Vaso-Occ...Hydroxyurea (HU) is approved in EU and U...
 - 
                                                                    
                            
                        
                        
                                                    Coretta Jenerette, PhD, RNCoretta M. Jenerette, PhD, RN, CNE, earn...
 - 
                                                                    
                            
                        
                        
                                                    Kids With Sickle Cell Anemia are More Sedentary Than Healthy Peers, Study SuggestsChildren and adolescents with sickle cel...
 
		   
                
		
	  
		
 +myBinder